Which Treatment for Nonalcoholic Fatty Liver Disease?

Author(s): S. Moscatiello, R. Marzocchi, N. Villanova, E. Bugianesi, G. Marchesini

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 8 , Issue 8 , 2008

Become EABM
Become Reviewer
Call for Editor


Subjects with nonalcoholic fatty liver disease are at risk of progressive liver failure. Lifestyle changes including weight-loss strategies and increased physical activity remain the first-line approach, but a few pharmacological treatments have also been successfully tested. Several drugs improve biochemistry, only a few improve histology; in all cases, the results were not sustained after treatment stop. Pharmacological treatment is not so far indicated outside controlled clinical trials with histological outcomes.

Keywords: Orlistat, weight loss, Metformin, statins, Lipid peroxidation, diabetes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [767 - 775]
Pages: 9
DOI: 10.2174/138955708784912193
Price: $65

Article Metrics

PDF: 3